Nvidia Jumps As China Chip Sales Move Toward Approval. Is Nvidia A Buy Now?
Nvidia stock jumps on Friday after reports that its China H200 chip was moving along toward getting a license approval.
BTC
ETH
USDT
USDC
XRP
SOL
TRX
FIGR_HELOC
HYPE
ZEC
DOGE
XMR
USDS
LEO
BTC
ETH
USDT
USDC
XRP
SOL
TRX
FIGR_HELOC
HYPE
ZEC
DOGE
XMR
USDS
LEO
BTC
ETH
USDT
USDC
XRP
SOL
TRX
FIGR_HELOC
HYPE
ZEC
DOGE
XMR
USDS
LEO
BTC
ETH
USDT
USDC
XRP
SOL
TRX
FIGR_HELOC
HYPE
ZEC
DOGE
XMR
USDS
LEO
Which part of the AI trade is more likely to better serve investors?
Most popular articles this week
Latest news from global stock markets, tech giants, and financial sectors
Browse ArticlesBitcoin, Ethereum, altcoins, DeFi, NFTs, and blockchain technology
Browse ArticlesGold, silver, oil, natural gas, and other precious commodities
Browse Articles
Nvidia stock jumps on Friday after reports that its China H200 chip was moving along toward getting a license approval.
Exclusive-Corporate America faces DEI reckoning in 2026, EEOC chair says
4 software stocks facing guidance risks in 2026, Morgan Stanley warns
Altimmune stock tumbles after MASH drug trial data
Mexican airline Volaris' shares take off after merger plans with Viva Aerobus
Rivian has been on a hot-streak since its "Autonomy & AI Day," where the EV startup announced an in-house silicon AI chip and outlined its next-generation...
Nvidia stock (NVDA) jumped as much as 3.7% in early trading on Friday following a Reuters report that the Trump administration began its review of Nvidia H...
The U.S. SEC has classified certain third-party Bitcoin mining contracts as securities in a $48 million fraud case, clarifying that the ruling applies to i...
Autozi stock soars after securing $90 million investment from CDIB
Lyft (LYFT) faces growing risk from the accelerating shift toward autonomous vehicles, which Wedbush
MESA, AZ / ACCESS Newswire / December 19, 2025 / Medical Care Technologies, Inc. (OTC PINK:MDCE) today announced that its first-ever AI-powered mobile appl...
The White House is getting ready to announce more deals with drugmakers aimed at lowering drug prices.